Document is current
Any future updates will be listed below
-
Authors
Su, Shan
Ye, Mei-Feng
Cai, Xiao-Ting
Bai, Xue
Huang, Zhi-Hao
Ma, Si-Cong
Zou, Jian-Jun
Wen, Yu-Xiang
Wu, Li-Juan
Guo, Xue-Jun
Zhang, Xian-Lan
Cen, Wen-Chang
Su, Duo-Hua
Huang, Hui-Yi
Dong, Zhong-Yi http://orcid.org/0000-0001-9967-0060
-
Funding
Funding for this research was provided by:
Young Scientists Fund (81802863, 82003304)
Natural Science Foundation of Guangdong Province (2018030310285)
- License Information
-
More Information
Article History
Received: 4 September 2021
Accepted: 22 November 2021
First Online: 20 December 2021
Declarations
:
: This retrospective cohort study was approved by the institutional review board of Guangzhou Chest Hospital and Nanfang Hospital. Patients had been informed of the possible risks and alternative treatment options before the anti-PD-(L)1 therapy or anti-tuberculosis treatment. All the patients had signed the informed consent for treatments.
: Not applicable.
: The authors declare that they have no competing interests.
